DiviDrip · SABS

SABS — SAB Biotherapeutics, Inc. Common Stock

SABS is SAB Biotherapeutics, Inc. Common Stock (Healthcare) — a non-dividend-paying stock. Trading at $3.79. Market cap: $345M. Capital Quality Rank: 79/100 — Elite compounder.

Stock snapshot

Price$3.79
Market cap$345M
SectorHealthcare
ExchangeXNAS
Pays dividendNo

Capital Quality & fundamentals

DiviDrip's Capital Analytics engine ranks every non-dividend stock 1-100 on a 4-factor composite (Shareholder Yield 30%, Cash-Flow ROI 25%, Operating Momentum 25%, Tail-Risk 20%) — sector-neutralized so a biotech isn't penalized for negative earnings the way a utility would be.

Capital Quality Rank (1-100)79 / 100 · Elite compounder
ROIC (TTM)-8.0%
Shareholder buyback yield0.00%
Altman Z-score zoneSafe

About SABS

SAB Biotherapeutics Inc is a clinical-stage biopharmaceutical company focused on developing multi-specific, high-potency, human immunoglobulin G (hIgG) to treat and prevent immune and autoimmune disorders. The company's lead product candidate, SAB-142, targets autoimmune Type 1 Diabetes (T1D) with a disease-modifying therapeutic approach that aims to change the T1D treatment paradigm by delaying onset and potentially preventing disease progression of Stage 3 T1D patients. It is focused on developing product candidates for disease targets where a differentiated approach has the greatest potential to be either first-in-class against novel targets against complex targets to treat diseases, including type 1 diabetes (T1D) and other autoimmune disorders.

Listed2021Employees86HQMiami Beach, FLSectorHealthcareWebsitesab.bio

Related non-dividend companies

Other non-dividend stocks investors research alongside SABS. Peer set from Massive news + returns similarity, filtered to names we currently track.

Frequently asked

What is SABS's current stock price?

SABS (SAB Biotherapeutics, Inc. Common Stock) is currently trading at $3.79.

Does SABS pay a dividend?

SABS (SAB Biotherapeutics, Inc. Common Stock) does not currently pay a regular dividend.

What is SABS's Capital Quality Rank?

SABS has a Capital Quality Rank of 79/100 — Elite compounder. This score blends ROIC, revenue growth, buybacks, and balance-sheet health.

Track SABS in DiviDrip

Add SABS to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.

Data refreshed 2026-08-30. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.

Related guides

DiviDrip is a free dividend portfolio tracker built by dividend investors, for dividend investors. Try it free — no payment, no upsell, ever. Read the How-To to see how each tool fits together, or browse the Glossary for every term defined plain-English.

Disclaimer: The information provided on this website/service is for informational purposes only and does not constitute financial, investment, or legal advice. Investing in stocks involves high risk, including the loss of principal. We are not responsible for any financial losses or damages resulting from your reliance on this data. Always consult with a qualified financial professional before making investment decisions.

Trademark Notice: Twylight Crow's Dividend Tracker (formerly indexed as DiviDrip) is an independent portfolio utility. This tool is not affiliated with, authorized, endorsed by, or in any way officially connected to Dividrip.com or its international affiliates.

Contact: dividrip@twylightcrow.com© 2026 Twylight Crow